MYRZAKHMETOVA BALZHAN SHAYZADAEVNA
Candidate of Biological Sciences, Professor,
Head of Laboratory.
Specialist in the fields of biosafety, epizootology, virology, vaccinology, immunology, cellular biotechnology, and specific prevention of infectious diseases.
Author of more than 105 scientific publications, including 21 papers with a non-zero impact
factor indexed in the Web of Science and Scopus databases. Holds 17 authorship certificates
related to the development of vaccine preparations.
Awarded the “Halyk Algysy” Medal in 2021,
the “Excellence in Healthcare” Badge in 2024,
and the Shakarim Medal in 2024.
Completed professional training at the Veterinary Academy of Xinjiang Uyghur Autonomous Region (China) in 2015,
at BioKhimPharm LLC (Vladimir, Russia) from 2015 to 2019,
at the National Veterinary Institute (Pulawy, Poland) in 2017,
and at the Veterinary Institute (Kraljevo, Serbia) in 2018.
Индекс Хирша по Web of Science — 6 и Scopus — 6.
ORCID ID — https://orcid.org/0000-0002-4141-7174
Scopus ID — 57215671527
Web of Science ID — HJZ-3744-2023
b.myrzakhmetova@biosafety.kz
+7(72636)7-22-28, вн. 146
Projects:
| АР05135323. | Development of a producer substrate of the lumpy skin disease virus for use in the technology of manufacturing vaccines and diagnostic preparations. |
| Initiative project | Development of a technology for producing a live culture vaccine against COVID-19. |
| Initiative project | Development of a tool and method for standardizing the immunogenicity of the vaccine against lumpy skin disease developed at the Research Institute for Biological Safety Problems (RIBSP). |
Research areas of the laboratory:
- Development of tools, methods, and measures against particularly dangerous infectious diseases, applied during epizootics/epidemics and bioterrorism.
- Identification and characterization of risks of particularly dangerous infectious diseases of enzootic and exotic nature for the territory of the Republic of Kazakhstan.
- Conducting research with causative agents of particularly dangerous infectious diseases of animals and humans to study their biological properties and to prepare standardized samples for research and the production of biopreparations.
Innovative developments of the laboratory:
- Development of the inactivated vaccine QazVac (QazCOVID-in) against COVID-19 coronavirus infection.
- Development of the live dry vaccine QazCOVID-live against COVID-19 coronavirus infection.
Main publications of the laboratory: